- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Contact
Pre-clinical studies.
Confidence in getting your product to market
Pre-clinical development studies
Accelerate timelines with expertise you can trust.
Our team of experts can support your pre-clinical development and accelerate the identification of the best candidate and formulation strategy to move quickly to Phase 1 clinical trials.
UpperSolv™ development platform
Rapidly identify a successful formulation strategy.
Our early formulation platform, UpperSolv™ outlines a parallel integrated formulation and biopharmaceutical screening protocol that can rapidly compare a range of enabling formulation strategies that can be translated into clinical processes and products.
Pharmaceutical Spray Drying
Overcoming poor solubility and bioavailability challenges.
We’re specialists in the use of pharmaceutical spray drying to improve the solubility and bioavailability of your formulation, helping to enhance the dissolution rate and stability.
Frequently Asked Questions
Here are some frequently asked questions about pre-clinical development.
How do you optimise your CDMO services to meet Phase 2 clinical trials requirements?
At Upperton, we understand that Phase 2 trials are crucial for validating the therapeutic potential identified in Phase 1. Our specialised services are designed to manage the increased complexity and stakes of this phase. We offer:
- Refined Formulation Development: Leveraging Phase 1 data, we optimize formulations to enhance efficacy, minimize side effects, and improve patient adherence.
- Scalable Manufacturing Solutions: As you transition to mid-scale manufacturing, we ensure consistent quality while maintaining the flexibility to adapt based on trial results.
- Expert Regulatory Guidance: We provide tailored support to navigate the specific regulatory requirements of Phase 2, ensuring compliance and thorough documentation.
Can Upperton provide regulatory support during Phase 2?
Yes, our regulatory affairs support service includes expert guidance, detailed documentation support regarding regulatory submissions, IND amendments and briefing packages.
Get in touch
If you’re looking to work with a CDMO that is flexible and nimble, then we’re here to help.